Modern Pathology

Article	Citations
COVID-19 pulmonary pathology: a multi-institutional autopsy cohort from Italy and New York City	366
A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression	346
Digital pathology and artificial intelligence in translational medicine and clinical practice	250
In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19	248
SARS-CoV-2 can infect the placenta and is not associated with specific placental histopathology: a series of 19 placentas from COVID-19-positive mothers	205
Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience	183
Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data	179
New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia	150
Classification and reporting guidelines for the pathology diagnosis of placenta accreta spectrum (PAS) disorders: recommendations from an expert panel	137
Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia	123
Novel artificial intelligence system increases the detection of prostate cancer in whole slide images of core needle biopsies	116
Validation of a digital pathology system including remote review during the COVID-19 pandemic	114
Development of a prognostic model for mortality in COVID-19 infection using machine learning	114
TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer	104
Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer	99
Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists	98
Lung neuroendocrine neoplasms: recent progress and persistent challenges	95
Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19	93
Comparison of three PD-L1 immunohistochemical assays in head and neck squamous cell carcinoma (HNSCC)	83
Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review	82
A pan-cancer analysis of PD-L1 immunohistochemistry and gene amplification, tumor mutation burden and microsatellite instability in 48,782 cases	80
Quality control stress test for deep learning-based diagnostic model in digital pathology	80
Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer	79
DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma	79
Counting mitoses: SI(ze) matters!	77

An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracy	71
Prediction of early recurrence of hepatocellular carcinoma after resection using digital pathology images assessed by machine learning	69
Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC)	68
NTRK insights: best practices for pathologists	68
Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer	67
Homologous recombination deficiency (HRD) score in germline BRCA2- versus ATM-altered prostate cancer	66
Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization	65
HER2-low breast cancers: incidence, HER2 staining patterns, clinicopathologic features, MammaPrint and BluePrint genomic profiles	62
Mesonephric and mesonephric-like carcinomas of the female genital tract: molecular characterization including cases with mixed histology and matched metastases	62
Histiocytic hyperplasia with hemophagocytosis and acute alveolar damage in COVID-19 infection	60
PD-L1 expression in gastric cancer: interchangeability of 22C3 and 28-8 pharmDx assays for responses to immunotherapy	60
p53 immunohistochemistry in endometrial cancer: clinical and molecular correlates in the PORTEC-3 trial	59
ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217	59
Integrating digital pathology into clinical practice	57
Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusions	56
Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointesti	56
EWSR1/FUS–CREB fusions define a distinctive malignant epithelioid neoplasm with predilection for mesothelial-lined cavities	55
Four major patterns of placental injury: a stepwise guide for understanding and implementing the 2016 Amsterdam consensus	54
Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer	49
Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification	49
Tumor spread through air spaces (STAS): prognostic significance of grading in non-small cell lung cancer	49
Diffuse trophoblast damage is the hallmark of SARS-CoV-2-associated fetal demise	48
Clinicopathological analysis of 34 Japanese patients with EBV-positive mucocutaneous ulcer	47
Liver biopsy findings in patients on immune checkpoint inhibitors	47
Novel uses of immunohistochemistry in breast pathology: interpretation and pitfalls	45
T-cell clones of uncertain significance are highly prevalent and show close resemblance to T-cell large granular lymphocytic leukemia. Implications for laboratory diagnostics	45
Biomarkers of response to checkpoint inhibitors beyond PD-L1 in lung cancer	45
Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome	44
Fibroepithelial lesions revisited: implications for diagnosis and management	43
Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases	42
Frequent traces of EBV infection in Hodgkin and non-Hodgkin lymphomas classified as EBV-negative by routine methods: expanding the landscape of EBV-related lymphomas	41
The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime	41
Genomic landscape of endometrial carcinomas of no specific molecular profile	41
Pleural mesothelioma classification—update and challenges	40
NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker	40
DICER1-associated central nervous system sarcoma in children: comprehensive clinicopathologic and genetic analysis of a newly described rare tumor	40
Molecular characterization of diffuse malignant peritoneal mesothelioma	40
Artificial intelligence-assisted system for precision diagnosis of PD-L1 expression in non-small cell lung cancer	40
Genetic and clinical correlates of entosis in pancreatic ductal adenocarcinoma	40
Interpretable multimodal deep learning for real-time pan-tissue pan-disease pathology search on social media	38
Molecular characterization of invasive and in situ squamous neoplasia of the vulva and implications for morphologic diagnosis and outcome	38
Cribriform architecture in radical prostatectomies predicts oncological outcome in Gleason score 8 prostate cancer patients	38
Deep convolutional neural network-based classification of cancer cells on cytological pleural effusion images	37
Amsterdam International Consensus Meeting: tumor response scoring in the pathology assessment of resected pancreatic cancer after neoadjuvant therapy	37
Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney	37
A machine learning algorithm for simulating immunohistochemistry: development of SOX10 virtual IHC and evaluation on primarily melanocytic neoplasms	36
DEK-AFF2 fusion-associated papillary squamous cell carcinoma of the sinonasal tract: clinicopathologic characterization of seven cases with deceptively bland morphology	36
Low-grade oncocytic renal tumor (LOT): mutations in mTOR pathway genes and low expression of FOXI1	36
Deep learning prediction of BRAF-RAS gene expression signature identifies noninvasive follicular thyroid neoplasms with papillary-like nuclear features	36
Novel BRAF gene fusions and activating point mutations in spindle cell sarcomas with histologic overlap with infantile fibrosarcoma	35

Invasive squamous cell carcinomas and precursor lesions on UV-exposed epithelia demonstrate concordant genomic complexity in driver genes	35
EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma	35
Clinicopathologic and molecular analysis of embryonal rhabdomyosarcoma of the genitourinary tract: evidence for a distinct DICER1-associated subgroup	34
Genetic characteristics of gastric-type mucinous carcinoma of the uterine cervix	34
Identification of nodal micrometastasis in colorectal cancer using deep learning on annotation-free whole-slide images	34
Diverse immune environments in human lung tuberculosis granulomas assessed by quantitative multiplexed immunofluorescence	33
YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases	33
Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome	32
The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy	32
Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile	32
Undifferentiated round cell sarcoma with BCOR internal tandem duplications (ITD) or YWHAE fusions: a clinicopathologic and molecular study	31
Recommendations on compiling test datasets for evaluating artificial intelligence solutions in pathology	31
Nuclear expression of DDIT3 distinguishes high-grade myxoid liposarcoma from other round cell sarcomas	31
Lipoblastomas presenting in older children and adults: analysis of 22 cases with identification of novel PLAG1 fusion partners	31
Prognostic and predictive value of the newly proposed grading system of invasive pulmonary adenocarcinoma in Chinese patients: a retrospective multicohort study	31
Massively parallel sequencing analysis of 68 gastric-type cervical adenocarcinomas reveals mutations in cell cycle-related genes and potentially targetable mutations	31
Utility of methylthioadenosine phosphorylase immunohistochemical deficiency as a surrogate for CDKN2A homozygous deletion in the assessment of adult-type infiltrating astrocytoma	31
A new tool for technical standardization of the Ki67 immunohistochemical assay	30
Histopathologic features and molecular genetic landscape of HER2-amplified endometrial carcinomas	30
A large-scale internal validation study of unsupervised virtual trichrome staining technologies on nonalcoholic steatohepatitis liver biopsies	30
Novel GATA6-FOXO1 fusions in a subset of epithelioid hemangioma	30
Invasive apocrine carcinoma of the breast: clinicopathologic features and comprehensive genomic profiling of 18 pure triple-negative apocrine carcinomas	30
Prognostic impact of tumor microvessels in intrahepatic cholangiocarcinoma: association with tumor-infiltrating lymphocytes	30
“Inflammatory Leiomyosarcoma” and “Histiocyte-rich Rhabdomyoblastic Tumor”: a clinicopathological, immunohistochemical and genetic study of 13 cases, with a proposal for reclassification as “Inflammat	30
TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1	29
Assessment of deep learning assistance for the pathological diagnosis of gastric cancer	29
E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements	29
Myxoinflammatory fibroblastic sarcoma: an immunohistochemical and molecular genetic study of 73 cases	29
Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma	29
Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas	29
Recurrent MEIS1-NCOA2/1 fusions in a subset of low-grade spindle cell sarcomas frequently involving the genitourinary and gynecologic tracts	29
Deep learning-based histotype diagnosis of ovarian carcinoma whole-slide pathology images	29
Myxoid pleomorphic liposarcoma—a clinicopathologic, immunohistochemical, molecular genetic and epigenetic study of 12 cases, suggesting a possible relationship with conventional pleomorphic liposarcom	29
EWSR1-PATZ1-rearranged sarcoma: a report of nine cases of spindle and round cell neoplasms with predilection for thoracoabdominal soft tissues and frequent expression of neural and skeletal muscle mar	28
Epstein–Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship	28
The Role of Artificial Intelligence in Accurate Interpretation of HER2 Immunohistochemical Scores 0 and 1+ in Breast Cancer	28
Spatial immunoprofiling of the intratumoral and peritumoral tissue of renal cell carcinoma patients	28
High-grade transformation of low-grade endometrial stromal sarcomas lacking YWHAE and BCOR genetic abnormalities	28
Clinical, morphologic, and genomic findings in ROS1 fusion Spitz neoplasms	27
MicroRNA signatures associated with lymph node metastasis in intramucosal gastric cancer	27
Prognostic impact of tumor budding in endometrial carcinoma within distinct molecular subgroups	27
Detection and assessment of capsular invasion, vascular invasion and lymph node metastasis volume in thyroid carcinoma using microCT scanning of paraffin tissue blocks (3D whole block imaging): a proo	27
Reproducibility of scoring criteria for HER2 immunohistochemistry in endometrial serous carcinoma: a multi-institutional interobserver agreement study	27
MIXTURE of human expertise and deep learning—developing an explainable model for predicting pathological diagnosis and survival in patients with interstitial lung disease	27
Histologic grading of breast carcinoma: a multi-institution study of interobserver variation using virtual microscopy	27
Testosterone therapy and breast histopathological features in transgender individuals	27
Homologous Recombination Repair Deficiency: An Overview for Pathologists	27
HPV-independent, p53-wild-type vulvar intraepithelial neoplasia: a review of nomenclature and the journey to characterize verruciform and acanthotic precursor lesions of the vulva	27
Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma	27
IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis	27
Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring	26
Receptor conversion in metastatic breast cancer: analysis of 390 cases from a single institution	26
Pleuropulmonary blastoma-like peritoneal sarcoma: a newly described malignancy associated with biallelic DICER1 pathogenic variation	26
Differentiated exophytic vulvar intraepithelial lesion: Clinicopathologic and molecular analysis documenting its relationship with verrucous carcinoma of the vulva	26
The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features	26
Problematic breast tumors reassessed in light of novel molecular data	26
B7-H3 immune checkpoint expression is a poor prognostic factor in colorectal carcinoma	26
An unusual phenotype occurs in 15% of mismatch repair-deficient tumors and is associated with non-colorectal cancers and genetic syndromes	26
Evaluation of glucocorticoid-induced TNF receptor (GITR) expression in breast cancer and across multiple tumor types	25
ARID1A mutations and expression loss in non-small cell lung carcinomas: clinicopathologic and molecular analysis	25
Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death	25
Recurrent novel HMGA2-NCOR2 fusions characterize a subset of keratin-positive giant cell-rich soft tissue tumors	25
Hypersensitivity pneumonitis: new concepts and classifications	25
Comparison of solid tissue sequencing and liquid biopsy accuracy in identification of clinically relevant gene mutations and rearrangements in lung adenocarcinomas	25
A prognostic score for non-small cell lung cancer resected after neoadjuvant therapy in comparison with the tumor-node-metastases classification and major pathological response	25
Analysis of the immune checkpoint V-domain Ig-containing suppressor of T-cell activation (VISTA) in endometrial cancer	25
Prediction of non-muscle invasive bladder cancer recurrence using machine learning of quantitative nuclear features	25
Prospective molecular classification of endometrial carcinomas: institutional implementation, practice, and clinical experience	25
Papillary neoplasms of the breast—reviewing the spectrum	25
NUTM1-rearranged colorectal sarcoma: a clinicopathologically and genetically distinctive malignant neoplasm with a poor prognosis	25
Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations	25
Tumor-infiltrating lymphocytes are associated with poor prognosis in invasive lobular breast carcinoma	24
Prognostic value of desmoplastic stroma in intrahepatic cholangiocarcinoma	24
Embryonal rhabdomyosarcoma of the uterine corpus: a clinicopathological and molecular analysis of 21 cases highlighting a frequent association with DICER1 mutations	24
A novel prognostic two-gene signature for triple negative breast cancer	24
Myeloid/lymphoid neoplasms with FLT3 rearrangement	24
TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas	24
Triple-negative breast lobular carcinoma: a luminal androgen receptor carcinoma with specific ESRRA mutations	24
Multiplex Immunohistochemistry and Immunofluorescence: A Practical Update for Pathologists	24
Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping: updated analysis of a prospective series of 2217 cases	24

The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go	24
High Interobserver Variability Among Pathologists Using Combined Positive Score to Evaluate PD-L1 Expression in Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma	24
Genomic evidence suggests that cutaneous neuroendocrine carcinomas can arise from squamous dysplastic precursors	23
Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinoma	23
Minimalist approaches to cancer tissue-of-origin classification by DNA methylation	23
Genotyping diagnosis of gestational trophoblastic disease: frontiers in precision medicine	23
Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses	23
Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry	23
Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1–KMT2A–YAP1 and VIM–KMT2A fusions	23
Characterization of TP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinoma	23
Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study	23
Artificial neural networks and pathologists recognize basal cell carcinomas based on different histological patterns	23
Do we need an updated classification of oncocytic renal tumors?	23
KRAS amplification in metastatic colon cancer is associated with a history of inflammatory bowel disease and may confer resistance to anti-EGFR therapy	22
Fusion partners of NTRK3 affect subcellular localization of the fusion kinase and cytomorphology of melanocytes	22
DICER1-associated sarcomas: towards a unified nomenclature	22
Next-generation sequencing reveals heterogeneous genetic alterations in key signaling pathways of mismatch repair deficient colorectal carcinomas	22
Clinicopathological and genomic characterization of BCORL1-driven high-grade endometrial stromal sarcomas	22
Loss of expression of YAP1 C-terminus as an ancillary marker for epithelioid hemangioendothelioma variant with YAP1-TFE3 fusion and other YAP1-related vascular neoplasms	22
Chromosomal and molecular pathway alterations in the neuroendocrine carcinoma and adenocarcinoma components of gastric mixed neuroendocrine–nonneuroendocrine neoplasm	22
Diffuse expression of MUC6 defines a distinct clinicopathological subset of pulmonary invasive mucinous adenocarcinoma	22
Activation of the RAS pathway through uncommon BRAF mutations in mucinous pancreatic cysts without KRAS mutation	22
Molecular landscape of vulvovaginal squamous cell carcinoma: new insights into molecular mechanisms of HPV-associated and HPV-independent squamous cell carcinoma	22
Endogenous APOBEC3B overexpression characterizes HPV-positive and HPV-negative oral epithelial dysplasias and head and neck cancers	22
Calcified chondroid mesenchymal neoplasms with FN1-receptor tyrosine kinase gene fusions including FGFR2, FGFR1, MERTK, NTRK1, and TEK: a molecular and clinicopathologic analysis	22
Adult NTRK-rearranged spindle cell neoplasms of the viscera: with an emphasis on rare locations and heterologous elements	22
p53 Immunohistochemical patterns in HPV-related neoplasms of the female lower genital tract can be mistaken for TP53 null or missense mutational patterns	22
Immunohistochemical detection of PAX-FOXO1 fusion proteins in alveolar rhabdomyosarcoma using breakpoint specific monoclonal antibodies	22
Breast cancer with neuroendocrine differentiation: an update based on the latest WHO classification	22
TSC loss is a clonal event in eosinophilic solid and cystic renal cell carcinoma: a multiregional tumor sampling study	21
Computer-Assisted Diagnosis of Lymph Node Metastases in Colorectal Cancers Using Transfer Learning With an Ensemble Model	21
RAF1 rearrangements are common in pancreatic acinar cell carcinomas	21
Clonal relationship and directionality of progression of synchronous endometrial and ovarian carcinomas in patients with DNA mismatch repair-deficiency associated syndromes	21
Lung-only melanoma: UV mutational signature supports origin from occult cutaneous primaries and argues against the concept of primary pulmonary melanoma	21
Expanding the clinicopathological spectrum of succinate dehydrogenase-deficient renal cell carcinoma with a focus on variant morphologies: a study of 62 new tumors in 59 patients	21
Intratumoral budding and automated CD8-positive T-cell density in pretreatment biopsies can predict response to neoadjuvant therapy in rectal adenocarcinoma	21
The histologic presentation of hepatitis E reflects patients' immune status and pre-existing liver condition	21
Oncocytic renal neoplasms with diffuse keratin 7 immunohistochemistry harbor frequent alterations in the mammalian target of rapamycin pathway	21
Heterozygous/dispermic complete mole confers a significantly higher risk for post-molar gestational trophoblastic disease	21
Assessment of the feasibility of frozen sections for the detection of spread through air spaces (STAS) in pulmonary adenocarcinoma	21
Association of artificial intelligence-powered and manual quantification of programmed death-ligand 1 (PD-L1) expression with outcomes in patients treated with nivolumab ± ipilimumab	21
Prediction of malignant transformation and recurrence of oral epithelial dysplasia using architectural and cytological feature specific prognostic models	20
Nodal cytotoxic peripheral T-cell lymphoma occurs frequently in the clinical setting of immunodysregulation and is associated with recurrent epigenetic alterations	20
Well differentiated papillary mesothelial tumor: a new name and new problems	20
Histological regression in melanoma: impact on sentinel lymph node status and survival	20
Nodular fasciitis: a comprehensive, time-correlated investigation of 17 cases	20
TERT promoter mutation is an objective clinical marker for disease progression in chondrosarcoma	20
Uterine PEComas: correlation between melanocytic marker expression and TSC alterations/TFE3 fusions	20
The clinicopathologic spectrum and genomic landscape of de-/trans-differentiated melanoma	20
TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma	20
Comprehensive genomic profiling of EWSR1/FUS::CREB translocation-associated tumors uncovers prognostically significant recurrent genetic alterations and methylation-transcriptional correlates	20
Recurrent KRAS mutations are early events in the development of papillary renal neoplasm with reverse polarity	20
EWSR1-WT1 gene fusions in neoplasms other than desmoplastic small round cell tumor: a report of three unusual tumors involving the female genital tract and review of the literature	20
Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases	20
Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association with pathological complete respons	19
Quantitative comparison of PD-L1 IHC assays against NIST standard reference material 1934	19
Intimal sarcomas and undifferentiated cardiac sarcomas carry mutually exclusive MDM2, MDM4, and CDK6 amplifications and share a common DNA methylation signature	19
Direct identification of ALK and ROS1 fusions in non-small cell lung cancer from hematoxylin and eosin-stained slides using deep learning algorithms	19
Comparative molecular analysis of testicular Leydig cell tumors demonstrates distinct subsets of neoplasms with aggressive histopathologic features	19
Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma	19
Identification of novel SSX1 fusions in synovial sarcoma	19
Detecting mismatch repair deficiency in solid neoplasms: immunohistochemistry, microsatellite instability, or both?	19
Clinico-pathologic predictors of patterns of residual disease following neoadjuvant chemotherapy for breast cancer	19
Multi-magnification-based machine learning as an ancillary tool for the pathologic assessment of shaved margins for breast carcinoma lumpectomy specimens	19
Nuclear expression of AFF2 C-terminus is a sensitive and specific ancillary marker for DEK::AFF2 carcinoma of the sinonasal tract	19
Associations of non-pedunculated T1 colorectal adenocarcinoma outcome with consensus molecular subtypes, immunoscore, and microsatellite status: a multicenter case-cohort study	19
Integrating artificial intelligence in pathology: a qualitative interview study of users' experiences and expectations	19
Recurrent YAP1::MAML2 fusions in “nodular necrotizing” variants of myxoinflammatory fibroblastic sarcoma: a comprehensive study of 7 cases	18
Adenoid Ameloblastoma Shares Clinical, Histologic, and Molecular Features With Dentinogenic Ghost Cell Tumor: The Histologic Spectrum of WNT Pathway–Altered Benign Odontogenic Tumors	18
Hybrid schwannoma–perineurioma frequently harbors VGLL3 rearrangement	18
Adenoid ameloblastoma harbors beta-catenin mutations	18
Melanoma with in-frame deletion of MAP2K1: a distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutations	18
Molecular and immunophenotypic characterization of anal squamous cell carcinoma reveals distinct clinicopathologic groups associated with HPV and TP53 mutation status	18
Genetic profiling and biomarkers in peripheral T-cell lymphomas: current role in the diagnostic work-up	18
Histopathologic features of breast cancer in Li–Fraumeni syndrome	18
PD-L1 expression, tumor-infiltrating lymphocytes, mismatch repair deficiency, EGFR alteration and HPV infection in sinonasal squamous cell carcinoma	18
Artificial intelligence for advance requesting of immunohistochemistry in diagnostically uncertain prostate biopsies	18
Genetic differences between benign phyllodes tumors and fibroadenomas revealed through targeted next generation sequencing	18
Automated identification of leukocyte subsets improves standardization of database-guided expert-supervised diagnostic orientation in acute leukemia: a EuroFlow study	17
MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological features	17
Molecular characterization of uterine and ovarian tumors with mixed epithelial and germ cell features confirms frequent somatic derivation	17
High expression of nuclear NRF2 combined with NFE2L2 alterations predicts poor prognosis in esophageal squamous cell carcinoma patients	17
The histologic diagnosis of usual interstitial pneumonia of idiopathic pulmonary fibrosis. Where we are and where we need to go	17
Association of HPV42 with digital papillary adenocarcinoma and the use of in situ hybridization for its distinction from acral hidradenoma and diagnosis at non-acral sites	17
Molecular and clinicopathologic characterization of intravenous leiomyomatosis	17
Clinicopathologic and genomic characterization of PD-L1-positive uterine cervical carcinoma	17
Updates in grading and invasion assessment in lung adenocarcinoma	17
Diagnostic utility of one-stop fusion gene panel to detect TFE3/TFEB gene rearrangement and amplification in renal cell carcinomas	17
Unique Patterns of Heterogeneous Mismatch Repair Protein Expression in Colorectal Cancer Unveil Different Degrees of Tumor Mutational Burden and Distinct Tumor Microenvironment Features	17
Clinicopathologic characterization of malignant chondroblastoma: a neoplasm with locally aggressive behavior and metastatic potential that closely mimics chondroblastoma-like osteosarcoma	17
TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition	17
Characterization of novel USP6 gene rearrangements in a subset of so-called cellular fibroma of tendon sheath	17
Optimization of an automated tumor-infiltrating lymphocyte algorithm for improved prognostication in primary melanoma	17
HNF1β is a sensitive and specific novel marker for yolk sac tumor: a tissue microarray analysis of 601 testicular germ cell tumors	16
Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge	16